Polymorphisms in the E-cadherin (CDH1) gene promoter and the risk of bladder cancer
- 31 December 2006
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 42 (18) , 3219-3227
- https://doi.org/10.1016/j.ejca.2006.05.033
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Bladder cancer: Epidemiology, staging and grading, and diagnosisUrology, 2005
- Reduced E-cadherin expression contributes to the loss of p27 kip1 -mediated mechanism of contact inhibition in thyroid anaplastic carcinomasCarcinogenesis: Integrative Cancer Research, 2005
- The E-cadherin −347G→GA promoter polymorphism and its effect on transcriptional regulationCarcinogenesis: Integrative Cancer Research, 2004
- Autoregulation of E-cadherin expression by cadherin–cadherin interactionsThe Journal of cell biology, 2003
- Cell Adhesion Proteins As Tumor SuppressorsJournal of Urology, 2002
- Characterization of DNA polymorphisms in the E-cadherin gene (CDH1) promoter regionMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2002
- E-cadherin regulates cell growth by modulating proliferation-dependent β-catenin transcriptional activityThe Journal of cell biology, 2001
- The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor geneTrends in Biochemical Sciences, 1999
- E-Cadherin–dependent Growth Suppression is Mediated by the Cyclin-dependent Kinase Inhibitor p27KIP1The Journal of cell biology, 1998
- Induction of polarized cell-cell association and retardation of growth by activation of the E-cadherin-catenin adhesion system in a dispersed carcinoma line.The Journal of cell biology, 1994